Home
Scholarly Works
The use of an FDA-NDA database to assess the risk...
Conference

The use of an FDA-NDA database to assess the risk of exposing patients with chronic stable angina to placebo-controlled trials

Authors

Clark PI; Yusuf S; Glasser SP; Lipicky R

Volume

9

Pagination

pp. 249-250

Publisher

Elsevier

Publication Date

January 1, 1988

DOI

10.1016/0197-2456(88)90090-6

Conference proceedings

Contemporary Clinical Trials

Issue

3

ISSN

1551-7144
View published work (Non-McMaster Users)

Contact the Experts team